期刊文献+

Imiquimod-induced localized vitiligo-like hypopigmentation

原文传递
导出
摘要 Introduction Imiquimod is an immune response modifier,currently the 5% imiquimod cream is approved for treatment of extemal genital,perianal warts,superficial basal cell carcinoma,and actinic keratoses.Its anti-viral activity and anti-tumoral activity seem to be dependent on focal activation of the immune system with induction,synthesis,and release of cytokines,such as interferonalpha,interleukin-12 and tumor necrosis factor alpha[1-2].
出处 《International Journal of Dermatology and Venereology》 2018年第3期189-192,共4页 国际皮肤性病学杂志(英文)
  • 相关文献

参考文献2

二级参考文献2

  • 1David CV, Nguyen H, Goldenberg G. Imiquimod: a review of off-label clinical applications. J Drugs Dermatol 2011 ; 10:1300-1306.
  • 2Mclnturff .IE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125: 1-8.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部